UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 419

Sortiert nach

Endothelial Dysfunction in Hypertension: Current Concepts and Clinical Implications

Frontiers in medicine, 2022-01, Vol.8, p.798958-798958

2022

Link zum Volltext

Verfügbarkeit prüfen

Hypertension and Heart Failure: From Pathophysiology to Treatment

International journal of molecular sciences, 2024-06, Vol.25 (12), p.6661

2024

Link zum Volltext

Verfügbarkeit prüfen

Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure

International journal of molecular sciences, 2024-02, Vol.25 (5), p.2484

2024

Link zum Volltext

Verfügbarkeit prüfen

New Insights into Endothelial Dysfunction in Cardiometabolic Diseases: Potential Mechanisms and Clinical Implications

International journal of molecular sciences, 2024-03, Vol.25 (5), p.2973

2024

Link zum Volltext

Verfügbarkeit prüfen

New Insight in Cardiorenal Syndrome: From Biomarkers to Therapy

International journal of molecular sciences, 2023-03, Vol.24 (6), p.5089

2023

Link zum Volltext

Verfügbarkeit prüfen

Mitochondrial Dysfunction in Heart Failure: From Pathophysiological Mechanisms to Therapeutic Opportunities

International journal of molecular sciences, 2024-02, Vol.25 (5), p.2667

2024

Link zum Volltext

Verfügbarkeit prüfen

Natriuretic Peptides: It Is Time for Guided Therapeutic Strategies Based on Their Molecular Mechanisms

International journal of molecular sciences, 2023-03, Vol.24 (6), p.5131

2023

Link zum Volltext

Verfügbarkeit prüfen

Obesity and cardiovascular disease: An executive document on pathophysiological and clinical links promoted by the Italian Society of Cardiovascular Prevention (SIPREC)

Frontiers in cardiovascular medicine, 2023-03, Vol.10, p.1136340-1136340

2023

Link zum Volltext

Verfügbarkeit prüfen

cis -Acting Element at the 5' Noncoding Region of Tacaribe Virus S RNA Modulates Genome Replication

Journal of virology, 2023-03, Vol.97 (3), p.e0012523-e0012523

2023

Link zum Volltext

Verfügbarkeit prüfen

The effect of mindfulness on decision-making, inhibitory control, and impulsivity of substance use disorder in-treatment patients: A randomized clinical trial

PloS one, 2023-11, Vol.18 (11), p.e0293502-e0293502

2023

Link zum Volltext

Verfügbarkeit prüfen

The Virus–Host Interplay in Junín Mammarenavirus Infection

Viruses, 2022-05, Vol.14 (6), p.1134

2022

Link zum Volltext

Verfügbarkeit prüfen

A novel fission yeast platform to model N-glycosylation and the bases of congenital disorders of glycosylation type I

Journal of cell science, 2022-03, Vol.135 (5)

2022

Link zum Volltext

Verfügbarkeit prüfen

A Contemporary View of Natriuretic Peptides in the SARS-CoV-2 Era

Frontiers in physiology, 2021-07, Vol.12, p.643721-643721

2021

Link zum Volltext

Verfügbarkeit prüfen

Role of oxidative stress in the process of vascular remodeling following coronary revascularization

International journal of cardiology, 2018-10, Vol.268, p.27-33

2018

Link zum Volltext

Verfügbarkeit prüfen

Analysis of Lipid-linked Oligosaccharides Synthesized in vivo in Schizosaccharomyces pombe

Bio-protocol, 2022-09, Vol.12 (18)

2022

Link zum Volltext

Verfügbarkeit prüfen

Sacubitril/Valsartan as a Therapeutic Tool Across the Range of Heart Failure Phenotypes and Ejection Fraction Spectrum

Frontiers in physiology, 2021-08, Vol.12, p.652163-652163

2021

Link zum Volltext

Verfügbarkeit prüfen

Nuclease Activity of the Junín Virus Nucleoprotein C-Terminal Domain

Viruses, 2023-08, Vol.15 (9), p.1818

2023

Link zum Volltext

Verfügbarkeit prüfen

Polymorphic variants at NDUFC2, encoding a mitochondrial complex I subunit, associate with cardiac hypertrophy in human hypertension

Molecular medicine (Cambridge, Mass.), 2023-08, Vol.29 (1), p.107-107, Article 107

2023

Link zum Volltext

Verfügbarkeit prüfen

Abrogation of glucosidase I–mediated glycoprotein deglucosylation results in a sick phenotype in fission yeasts: Model for the human MOGS-CDG disorder

The Journal of biological chemistry, 2018-12, Vol.293 (52), p.19957-19973

2018

Link zum Volltext

Verfügbarkeit prüfen

Sacubitril/valsartan for heart failure with preserved ejection fraction and resistant hypertension: one shot for a double strike?

European heart journal, 2021-09, Vol.42 (36), p.3753-3755

2021

Link zum Volltext

Verfügbarkeit prüfen

Sacubitril/Valsartan: Potential Impact of ARNi "Beyond the Wall" of ACE2 on Treatment and Prognosis of Heart Failure Patients With Coronavirus Disease-19

Frontiers in cardiovascular medicine, 2020-11, Vol.7, p.616564-616564

2020

Link zum Volltext

Verfügbarkeit prüfen

Vegetative forms of Clostridium chauvoei trigger apoptotic and inflammatory responses on macrophages

Anaerobe, 2022-10, Vol.77, p.102616-102616, Article 102616

2022

Link zum Volltext

Verfügbarkeit prüfen

Lipoprotein (a) is related to coronary atherosclerotic burden and a vulnerable plaque phenotype in angiographically obstructive coronary artery disease

Atherosclerosis, 2016-03, Vol.246, p.214-220

2016

Link zum Volltext

Verfügbarkeit prüfen

β-Blockers and Erectile Dysfunction in Heart Failure. Between Myth and Reality

Reviews in cardiovascular medicine, 2022-05, Vol.23 (5), p.173

2022

Link zum Volltext

Verfügbarkeit prüfen

Cardiometabolic phenotype of heart failure with preserved ejection fraction as a target of sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide receptor agonists

Cardiovascular research, 2021-07, Vol.117 (9), p.1992-1994

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 419

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(380)
Mit Volltextzugriff
(379)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(5)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Endothelial Dysfunction in Hypertension: Current Concepts and Clinical Implications

Hypertension and Heart Failure: From Pathophysiology to Treatment

Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure

New Insights into Endothelial Dysfunction in Cardiometabolic Diseases: Potential Mechanisms and Clinical Implications

New Insight in Cardiorenal Syndrome: From Biomarkers to Therapy

Mitochondrial Dysfunction in Heart Failure: From Pathophysiological Mechanisms to Therapeutic Opportunities

Natriuretic Peptides: It Is Time for Guided Therapeutic Strategies Based on Their Molecular Mechanisms

Obesity and cardiovascular disease: An executive document on pathophysiological and clinical links promoted by the Italian Society of Cardiovascular Prevention (SIPREC)

cis -Acting Element at the 5' Noncoding Region of Tacaribe Virus S RNA Modulates Genome Replication

The effect of mindfulness on decision-making, inhibitory control, and impulsivity of substance use disorder in-treatment patients: A randomized clinical trial

The Virus–Host Interplay in Junín Mammarenavirus Infection

A novel fission yeast platform to model N-glycosylation and the bases of congenital disorders of glycosylation type I

A Contemporary View of Natriuretic Peptides in the SARS-CoV-2 Era

Role of oxidative stress in the process of vascular remodeling following coronary revascularization

Analysis of Lipid-linked Oligosaccharides Synthesized in vivo in Schizosaccharomyces pombe

Sacubitril/Valsartan as a Therapeutic Tool Across the Range of Heart Failure Phenotypes and Ejection Fraction Spectrum

Nuclease Activity of the Junín Virus Nucleoprotein C-Terminal Domain

Polymorphic variants at NDUFC2, encoding a mitochondrial complex I subunit, associate with cardiac hypertrophy in human hypertension

Abrogation of glucosidase I–mediated glycoprotein deglucosylation results in a sick phenotype in fission yeasts: Model for the human MOGS-CDG disorder

Sacubitril/valsartan for heart failure with preserved ejection fraction and resistant hypertension: one shot for a double strike?

Sacubitril/Valsartan: Potential Impact of ARNi "Beyond the Wall" of ACE2 on Treatment and Prognosis of Heart Failure Patients With Coronavirus Disease-19

Vegetative forms of Clostridium chauvoei trigger apoptotic and inflammatory responses on macrophages

Lipoprotein (a) is related to coronary atherosclerotic burden and a vulnerable plaque phenotype in angiographically obstructive coronary artery disease

β-Blockers and Erectile Dysfunction in Heart Failure. Between Myth and Reality

Cardiometabolic phenotype of heart failure with preserved ejection fraction as a target of sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide receptor agonists

Suchergebnisse filtern